Login to Your Account

Orbimed targeting China, India investments with record $551M Asia fund

By David Ho
Staff Writer

Wednesday, September 13, 2017

HONG KONG – Orbimed said it raised around $551 million in its third Asia-focused private equity fund, Orbimed Asia Partners III (OAP3), nearly doubling the $325 million raised for the previous fund in September 2014.

To continue reading subscribe now to BioWorld Asia (formerly International)

Learn More about BioWorld Asia (formerly International)

Already a subscriber? Sign In or Buy now to activate your subscription